News FDA approves new uses for two Roche drugs FDA hands out new indications for Tecentriq and Lucentis.
News Opdivo still clear immunotherapy leader despite Keytruda gai... Immunotherapy takes on rivals from Roche and BMS.
News Roche's Tecentriq approved for UK early access Tecentriq is latest immunotherapy available on the scheme.
Roche Roche muscling into melanoma with Tecentriq Swiss pharma looking to combine immunotherapy with already marketed drugs.
Cancer Positive results for Pacific Edge's bladder cancer diagnosti... Cancer diagnostic company Pacific Edge has revealed positive trial results for its Cxbladder Monitor gene expression test.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
